###begin article-title 0
Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes
###end article-title 0
###begin p 1
###xml 38 65 38 65 <email xmlns:xlink="http://www.w3.org/1999/xlink">gwendalyn.randolph@mssm.edu</email>
CORRESPONDENCE Gwendalyn J. Randolph: gwendalyn.randolph@mssm.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
Observations that dendritic cells (DCs) constitutively enter afferent lymphatic vessels in many organs and that DCs in some tissues, such as the lung, turnover rapidly in the steady state have led to the concept that a major fraction of lymph node DCs are derived from migratory DCs that enter the lymph node through upstream afferent lymphatic vessels. We used the lysozyme M-Cre reporter mouse strain to assess the relationship of lymph node and nonlymphoid organ DCs. Our findings challenge the idea that a substantial proportion of lymph node DCs derive from the upstream tissue during homeostasis. Instead, our analysis suggests that nonlymphoid organ DCs comprise a major population of DCs within lymph nodes only after introduction of an inflammatory stimulus.
###end p 3
###begin p 4
Abbreviations used: BAL, bronchoalveolar lavage; EGFP, enhanced GFP; LP, lamina propria; LysM, lysozyme M; MDP, macrophage DC progenitor; TRITC, tetramethylrhodoamine-5-(and-6)-isothiocyanate.
###end p 4
###begin p 5
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 1029 1030 1029 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1241 1242 1241 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1386 1387 1386 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1388 1390 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1474 1476 1474 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1577 1579 1577 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
Afferent lymphatic vessels transport interstitial fluid and cells from tissues before terminating in draining lymph nodes. DCs and T cells are the major cellular components of afferent lymph (1-3), but very few DCs enter efferent lymph (3, 4). Inflammatory stimuli increase the rate of afferent lymphatic DC output by approximately an order of magnitude (5). However, inflammatory stimuli are not required for DC and T cell entry into afferent lymphatics, because the recovery of these cells from lymph in the steady state is still substantial (5). Indeed, the projected afferent lymphatic DC output is high enough to fully supply all lymph node DCs, even considering a short DC lifespan (4). Thus, from these early observations, it seemed quite plausible that lymph was the major source of lymph node DCs in general. Reinforcing this possibility were other early studies revealing that DCs purified from the spleen can, upon adoptive transfer, immigrate to lymph nodes through lymphatic vessels but not through the bloodstream (6). Furthermore, revelations that the steady-state turnover of pulmonary DCs is very rapid fit well with the interpretation that this fast turnover was linked to a high rate of DC entry into afferent lymphatics (7). Functionally, DCs that migrate through afferent lymph to lymph nodes in the steady state transport parenchymal antigens from various organs (8-10), and such transport may facilitate the initiation of peripheral immune tolerance (11), possibly working in concert with other mechanisms that give rise to tolerance within lymph nodes (12).
###end p 5
###begin p 6
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 300 301 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 307 309 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 311 313 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 610 612 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 859 861 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 863 865 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
More recently, our understanding of DC homeostasis in lymph nodes has evolved to include not only lymph-migrating DCs but also a role for DCs that enter from blood vessels, the specialized high endothelial venules, to maintain specific DC subsets, notably plasmacytoid DCs (13, 14) and mouse CD8alpha+ DCs (15, 16). Accordingly, a recent review of DC biology suggested that half of the DCs within lymph nodes enter from the bloodstream, including the full complement of these specialized subsets, but the other half of DCs were still believed to arise from lymph-migrating tissue DCs (for review see reference 17). This conclusion was based in part on the notion that it is possible to readily identify which DCs traveled to lymph nodes through afferent lymph based on combinations of various markers, such as higher expression of MHC II in the steady state (18, 19). However, the relationship between DCs bearing such markers and their presumed precursors derived from upstream tissue has not been established.
###end p 6
###begin p 7
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
Our past studies on the role of monocytes as a potential source of lymph-trafficking DCs (20-22) fueled our interest in the relationship between nonlymphoid organ DCs and lymph node DCs. Several recent studies have concluded that spleen DCs do not arise from monocytes using adoptive transfer approaches (23-26). In addition, a study in parabiotic mice suggested that monocytes are also not precursors for lymph node DCs, because blood monocytes and lymph node DCs exchanged between parabionts to differing extents (27). Strikingly, one of these studies indicated that, in strong contrast to spleen DCs, monocytes are precursors of peripheral nonlymphoid organ DCs (25), implying for the first time that DCs in lymphoid organs may have a distinct origin from DCs in nonlymphoid organs. However, little lineage analysis has been conducted in lymph nodes, which in contrast to the spleen, are positioned to serve as a nexus wherein lymphoid organ-resident DCs and nonlymphoid organ DCs would converge, presumably in equal proportions (17), to interact with lymphocytes and drive immune responses.
###end p 7
###begin p 8
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
Indications that nonlymphoid organ DCs may arise from monocytes (22, 25, 28), in contrast to other DCs, suggested to us an approach to analyze the proportion of lymph node DCs that might arise from DCs originating in upstream tissues. In this study, we used a popular reporter mouse line that uses the lysozyme promoter, active in many monocytes, to drive Cre recombinase (29) that subsequently removes a stop cassette upstream of enhanced GFP (EGFP) (30). Studies in this model fit well with the evidence that nonlymphoid organ and spleen DCs may be unrelated in origin and, most importantly, reveal that, against expectations and prevailing models in the field, only a minority of lymph node DCs in the steady state arises from DCs residing in upstream nonlymphoid organs. Instead, DCs that migrate through lymphatics from upstream tissues contribute substantially to the pool of lymph node DCs, mainly during inflammatory states.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 66 70 66 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Illustration of the utility of lysozyme M (LysM)-Cre x Rosa26-stopfloxEGFP mice to assess DC relationships with monocytes or other DC populations
###end title 10
###begin p 11
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 273 276 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
LysM is expressed by neutrophils and macrophages. Accordingly, LysM-Cre mice (29, 31) have been widely used to generate cell type-selective deletions of floxed genes or expression of floxed reporter markers, especially Rosa26 promoter-driven reporter genes. In these mice, Cre activity removes a stop cassette upstream of the floxed reporter in neutrophils and monocyte-derived macrophages. Neutrophils are not considered candidates for DC precursors, but monocytes may be precursors for at least some DC populations (20-22, 25). If only some DCs are derived from monocytes, and if the lysozyme promoter has low activity in other DC precursors, then the LysM-Cre reporter mice would be a useful tool to trace relationships between monocytes and DCs and possibly between different DC populations in vivo.
###end p 11
###begin p 12
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 196 197 196 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 239 241 239 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 297 299 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 369 370 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 372 380 372 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 561 562 561 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 712 713 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 739 740 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 781 782 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 840 841 840 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
When we analyzed blood monocytes in LysM-Cre x Rosa26-stopfloxEGFP mice in the steady state, the two subsets of circulating CD115hi blood monocytes (32-34) differed in the percentage that was EGFP+. Ly-6Chi monocytes (sometimes called Gr-1hi monocytes) were on average 55% EGFP+, whereas the Ly-6Clo monocyte subset (sometimes called Gr-1lo monocytes) averaged 75% EGFP+ (Fig. 1 A). Since their discovery in mice, these two subsets have not been further subdivided, and accordingly, we found no obvious differences in cell-surface markers between EGFP- and EGFP+ monocyte subpopulations. Furthermore, transfer of EGFP- monocytes into congenic recipient mice revealed that, 1 d later, many of the transferred EGFP- monocytes had become EGFP+ (unpublished data), indicating that EGFP- monocytes do not maintain a distinct population from EGFP+ monocytes. Instead, the failure of EGFP to be uniformly expressed by a given monocyte subset in blood is more likely caused by the stochastic failure of strong lysozyme promoter usage or Cre-mediated excision of the stop cassette in the reporter construct.
###end p 12
###begin p 13
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 0 113 0 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EGFP reporter expression in LysM-Cre &#215; Rosa26-stop<sup>flox</sup>EGFP mice by blood monocytes and spleen macrophages or DCs.</bold>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 499 500 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 744 745 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 779 780 779 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 795 797 795 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 841 845 841 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 1021 1023 1021 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1129 1130 1129 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1136 1138 1136 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1348 1352 1342 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 1445 1446 1435 1436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1464 1465 1450 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1575 1577 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1685 1686 1671 1672 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1692 1694 1678 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
###xml 1385 1389 <span type="species:ncbi:10090">mice</span>
###xml 1717 1722 <span type="species:ncbi:10090">mouse</span>
###xml 1743 1747 <span type="species:ncbi:10090">mice</span>
###xml 1809 1814 <span type="species:ncbi:10090">mouse</span>
###xml 1829 1833 <span type="species:ncbi:10090">mice</span>
###xml 1971 1975 <span type="species:ncbi:10090">mice</span>
EGFP reporter expression in LysM-Cre x Rosa26-stopfloxEGFP mice by blood monocytes and spleen macrophages or DCs. (A) EGFP frequency in blood populations was analyzed. CD115 and Gr-1/Ly-6C stainings identified blood monocyte subsets in wild-type C57BL/6 mice, Rosa26-EGFP knock-in mice, or LysM-Cre x Rosa26-stopfloxEGFP mice. The percentage of each subset that expressed EGFP was analyzed. High side scatter (SSC) and lower levels of CD115 expression were used to discern neutrophils. Low SSC CD115- cells, which are mostly lymphocytes, were evaluated to measure the extent of promiscuous usage of the lysozyme promoter (reference 31). (right) Plot shows the percentage of EGFP of various blood populations in all mice enrolled in this study (n = 60). (B) The percentage of EGFP+ cells in CD115hi bone marrow cells in LysM-Cre x Rosa26-stopfloxEGFP mice was analyzed and plotted. A panel of lineage markers was first used to narrow down bone marrow cells that might be monocytes or MDPs. Bone marrow monocytes were CD115hi cells that coexpressed the lineage markers Gr-1 and/or CD11b (lineage stain 2), whereas MDPs were lineage- CD115hi cells (reference 37). Data represent the mean +/- SEM. (C) Stainings for CD11c, CD11b, CD8alpha, and B220 defined conventional DC subsets and other populations in steady-state spleens of LysM-Cre x Rosa26-stopfloxEGFP mice or Rosa26-GFP knock-in mice. Conventional DCs correspond to populations 1 (CD8alpha+ DCs), 3 (CD8alpha- DCs), and 4 (plasmacytoid DCs). Macrophages comprise gates 6 and 7, and gate 5 includes monocytes (reference 37). The percentage of EGFP in these and other designated populations was normalized to the percentage of EGFP+ Ly-6Chi monocytes in the same mouse. In the graphs, all mice studied are compiled, and each data point corresponds to one mouse. Two to three mice per group were handled per experiment. Horizontal bars on scatter plots represent means. In B, two experiments were performed with three mice in each.
###end p 13
###begin p 14
###xml 15 17 15 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 225 233 225 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 489 497 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 750 751 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 835 843 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
In blood, CD115lo cells are granulocytes, mostly high-scatter neutrophils, and 93% of these cells were EGFP+ on average, consistent with the expectation that the lysozyme promoter is most strongly transcribed in these cells (Fig. 1 A). Because of a low level of utilization of the lysozyme promoter by hematopoietic stem cells (31), populations other than neutrophils and monocyte-derived cells, such as lymphocytes, were EGFP+ at a low frequency, but this frequency (6% EGFP+ on average; Fig. 1 A) was substantially less than that of neutrophils or monocytes. As expected, control WT naive mice had no EGFP expression, whereas mice that have EGFP knocked into the Rosa26 locus for constitutive expression (35) showed that >98% of monocytes were EGFP+, thus indicating that the Rosa26 promoter is constitutively active in these cells (Fig. 1 A).
###end p 14
###begin p 15
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 169 177 169 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 283 284 283 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
In the bone marrow, monocytes are mainly Ly-6Chi monocytes (36), and these monocytes were EGFP+ at a frequency similar to their blood counterparts, averaging 50% EGFP+ (Fig. 1 B). In contrast, the recently described macrophage DC progenitors (MDPs) (24), identified as CD115+ lineage- cells (37), were EGFP+ to a lower frequency (14% on average; Fig. 1 B).
###end p 15
###begin p 16
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 828 829 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 877 878 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Although not all monocytes were EGFP+, we reasoned that populations of DC subsets derived from monocytes should express EGFP at a percentage at least equal to the percentage of monocytes that scored positive. If the lysozyme promoter remained or became active during the differentiation of DCs after the monocyte stage, the percentage of DCs positive for EGFP might exceed that of monocytes. However, DCs positive for EGFP at a percentage sufficiently high to meet the criterion for potentially being derived from monocytes would not prove that they originated from monocytes. Nonetheless, as long as the Rosa26 promoter upstream of the EGFP reporter remained active, DC populations expressing a much lower fraction of EGFP than blood monocytes certainly could not be derived primarily from monocytes, and most importantly, EGFP- DC populations could not be descendents of EGFP+ DCs or monocytes.
###end p 16
###begin p 17
###xml 74 78 74 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 328 336 328 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 495 497 495 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 664 672 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 680 683 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 688 689 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 693 694 689 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 724 732 720 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 760 763 756 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 772 773 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 859 861 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 913 921 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1242 1244 1238 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1269 1270 1265 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1324 1326 1320 1322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1354 1356 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1357 1359 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1361 1363 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1418 1419 1414 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1440 1442 1436 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1658 1659 1654 1655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1703 1711 1699 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 1737 1739 1733 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1822 1824 1818 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1825 1827 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 2007 2009 2003 2005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 2019 2022 2015 2018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 2048 2049 2044 2045 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2088 2096 2084 2092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 2184 2186 2180 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 2266 2274 2262 2270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 1084 1089 <span type="species:ncbi:10090">mouse</span>
###xml 1283 1288 <span type="species:ncbi:10090">mouse</span>
###xml 2082 2086 <span type="species:ncbi:10090">mice</span>
Thus, we next analyzed DC subsets in the spleens of LysM-Cre x Rosa26-stopfloxEGFP mice to determine if their propensity to express EGFP may differ from that of monocytes, as might be expected from previous work (23-26). When total CD11c+ cells were considered, EGFP+ frequency more closely matched that of MDPs than monocytes (Fig. 1 C). To assess spleen DCs more carefully, we analyzed various DC subsets by further flow cytometric staining and gating. Conventional DCs in the spleen are CD11chi cells that differentially express CD8alpha and CD11b, and based on these gates, we separately evaluated EGFP expression in these subsets, labeled as populations 1-3 (Fig. 1 C). CD11cintCD11b-B220+ cells were plasmacytoid DCs (Fig. 1 C, population 4). Other CD11cint or CD11c- populations that expressed high CD11b were likely splenic monocytes and macrophages (37), and these could be divided in three populations (Fig. 1 C, labeled populations 5-7). In our analyses, we used monocytes as a reference population to normalize the data and draw a direct comparison to monocytes. In every mouse analyzed, we calculated the percentage of EGFP expressed in a given spleen DC or macrophage population and divided this value by the percentage of Ly-6Chi monocytes that were EGFP+ in the same mouse, because DCs might arise from Ly-6Chi monocytes in some tissues (20-22, 25). If the percentage of a given DC subset that was EGFP+ was similar to Ly-6Chi monocytes, then the product of this division would produce a value of 1. Ratios substantially <1 would indicate populations that could not have received a majority of precursor input from monocytes or any other EGFP+ population. In the spleen, all DC subsets (Fig. 1 C, gated populations 1-4) (37) exhibited a low level of EGFP expression and, fitting with previous conclusions (23-26), did not meet the criterion for a potentially close relationship with monocytes. Failure to meet this criterion was not caused by inactivity at the Rosa26 promoter, because CD11chi and CD11cint cells were uniformly EGFP+ in control Rosa26-EGFP knock-in mice (Fig. 1 C). In contrast to DCs, monocytes and macrophages in the spleen (gated populations 5-7) (37) met or exceeded the minimal criterion for possible derivation from monocytes (Fig. 1 C), serving as a positive control for the approach taken.
###end p 17
###begin title 18
Reporter expression by nonlymphoid organ DCs is distinct from spleen DCs in the steady state
###end title 18
###begin p 19
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 224 232 224 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 316 317 316 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 441 443 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 461 469 461 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 503 505 503 505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 510 511 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 562 563 562 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 589 597 589 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 715 717 715 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 724 726 724 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 824 826 824 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 838 846 838 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
Next, we examined peripheral organ DCs in skin, lung, and small intestine in the steady state. Skin DCs were separated into epidermal DCs (Langerhans cells; Fig. 2 A) and dermal DCs that, as a whole, are CD11c+ and MHC II+ (Fig. 2 A, Dermal 1) (38). These tissue DC populations showed a much higher frequency of EGFP+ cells than that observed for spleen DCs, and overall, the frequency of EGFP+ skin DCs resembled the frequency seen in Ly-6Chi blood monocytes (Fig. 2 A). As noted previously (38), CD11bhiCD11c- cells in the dermis could be separated into MHC II+ and MHC II- populations (Fig. 2 A, Dermal 2 and 3, respectively). These cells likely include macrophages (38), with considerable heterogeneity in CD11bhi MHC IIlo cells. Overall, these populations also showed a frequency of EGFP expression that resembled Ly-6Chi monocytes (Fig. 2 A).
###end p 19
###begin p 20
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 0 124 0 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EGFP reporter expression in LysM-Cre &#215; Rosa26-stop<sup>flox</sup>EGFP mice by DCs and macrophages from skin, lung, and small intestine.</bold>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 285 287 285 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 351 353 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 360 362 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 397 398 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 580 581 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 586 588 586 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 598 599 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 664 665 664 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 671 673 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1034 1036 1030 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1043 1046 1039 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1257 1260 1253 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1267 1269 1263 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1275 1277 1271 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1339 1340 1335 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1381 1382 1377 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1388 1390 1384 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 696 701 <span type="species:ncbi:10090">mouse</span>
###xml 1413 1418 <span type="species:ncbi:10090">mouse</span>
###xml 1439 1443 <span type="species:ncbi:10090">mice</span>
###xml 1505 1510 <span type="species:ncbi:10090">mouse</span>
###xml 1525 1529 <span type="species:ncbi:10090">mice</span>
EGFP reporter expression in LysM-Cre x Rosa26-stopfloxEGFP mice by DCs and macrophages from skin, lung, and small intestine. (A) Single-cell suspensions were prepared from the epidermis and dermis. Epidermal DCs were CD11c+ langerin+, and dermal DCs were gated as CD11c+ CD11bhi MHC IIhi (dermal 1), CD11c- CD11bhi MHC IIhi (dermal 2), or CD11c- CD11bhi MHC IIlo (dermal 3). The percentage of EGFP+ cells in these populations was normalized to the percentage of EGFP+ Ly-6Chi monocytes in the same mouse. (B) The percentage of EGFP in the BAL and lung of the two DC subsets (CD103-CD11bhi and CD103+CD11blo) and macrophages was normalized to the percentage of EGFP+ Ly-6Chi monocytes in the same mouse. (C) Gated live cells derived from the small intestine LP (or LP associated with the villous tips during removal of the epithelium) were stained and analyzed to reveal populations expressing CD11c, CD11b, CD8alpha, and MHC II. The LP contained lymphocytes and three populations that resembled DCs and/or macrophages, including CD11chi MHC IIint cells that differed with respect to CD11b expression (LP1 and LP2). Population LP2 was also associated with villous tips processed along with the intestinal epithelium (Villi DC). The third population was CD11cint MHC IIhi CD11bhi (LP 3). The percentage of these LP populations that were EGFP+ was normalized to the percentage of EGFP+ Ly-6Chi monocytes in the same mouse. In each graph, all mice studied are compiled, and each data point corresponds to one mouse. Two to three mice per group were handled per experiment. Horizontal bars represent means.
###end p 20
###begin p 21
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 238 239 238 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 244 246 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 262 264 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 417 419 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 437 445 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 492 493 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 495 503 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 771 773 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 775 777 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 779 781 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
Pulmonary DCs are identified as CD11c+ cells with low autofluorescence, whereas CD11c+ cells with high autofluorescence are macrophages (22). Two subsets of pulmonary DCs exist, displaying differential expression of CD11b and CD103: CD103+CD11blo and CD103-CD11bhi DCs (22, 39, 40). Both DC subsets, whether recovered from the lung interstitium or bronchoalveolar lavage (BAL), were EGFP+ to a similar extent as Ly-6Chi blood monocytes (Fig. 2 B). Macrophages in the BAL were nearly 100% EGFP+ (Fig. 2 B), yielding a mean ratio of approximately2. Thus, as in the skin, DCs in the lung displayed considerable expression of EGFP, in contrast to spleen DCs and consistent with previous suggestions that blood monocytes may serve as a major precursor source for these cells (22, 25, 28).
###end p 21
###begin p 22
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 180 188 180 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 259 263 259 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 279 281 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 469 470 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 476 477 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 520 528 520 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 558 559 558 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 770 771 766 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 773 781 769 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 812 814 808 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 819 821 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 829 830 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 862 864 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 878 879 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1227 1235 1215 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1327 1328 1315 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1426 1434 1414 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1647 1655 1635 1643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 1765 1766 1753 1754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1785 1793 1773 1781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 1545 1549 <span type="species:ncbi:10090">mice</span>
In the small intestine, we analyzed DCs and/or macrophages in the lamina propria (LP). Two thirds of MHC II+ cells expressed high levels of CD11b and intermediate levels of CD11c (Fig. 2 C, gate 3/LP3). Most of these cells were EGFP+ in LysM-Cre x Rosa26-stopfloxEGFP mice. CD11chi cells with lower levels of MHC II could be separated into two populations based on differential surface expression of CD11b. One of these populations, representing from 4 to 10% of MHC II+ CD11c+ cells and expressing low levels of CD11b (Fig. 2 C, gate 1/LP1), was mainly EGFP- and stood out as the only potential DC population in any of the nonlymphoid organs examined that expressed EGFP at percentages as low as those observed for spleen DCs. However, this population was also CD8alpha+ (Fig. 2 C), resembling a subset of CD11chiCD11bloCD8alpha+ DCs in nearby Peyer's patches (41) and CD8alpha+ lymph node DCs in general. Indeed, this population may not be part of the LP proper but instead may be a contaminant from Peyer's patches, as we noticed that the population became progressively reduced in frequency (down to 4% of recovered DCs) as our skills in the dissection of the Peyer's patches away from the LP improved. Another population (Fig. 2 C, gate 2/LP2) expressed intermediate levels of EGFP that did not reach the frequency of EGFP+ cells observed in monocytes but that maintained a frequency higher than spleen DCs. These cells (Fig. 2 C, gate 2/LP2) are likely the DCs that populate the villi of the intestine and upper LP layers, because in some mice, we recovered DCs from villous tips that were removed while stripping the intestinal epithelium (Fig. 2 C, Villi DC), and the LP DCs recovered from these villi appeared identical in phenotype (not depicted) and EGFP+ frequency to LP2 (Fig. 2 C).
###end p 22
###begin p 23
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
Considering data from all of these organs together, we conclude that most nonlymphoid organ DCs or their precursors use the lysozyme promoter in the steady state. This feature distinguishes them from spleen DCs and is consistent with, but does not prove, that the origins of nonlymphoid organ DCs may be distinct from spleen DCs, as previously proposed (25).
###end p 23
###begin title 24
Nonlymphoid organ-derived DCs are scarce in lymph nodes
###end title 24
###begin p 25
###xml 364 365 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 491 502 491 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A&#8211;C</xref>
###xml 651 654 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 664 666 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 710 711 710 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 742 750 742 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 D</xref>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
Because it is thought that lymph nodes receive substantial seeding by DCs that emigrate from upstream nonlymphoid organs through the afferent lymphatics (see Introduction), we expected to find that lymph node DCs, and discrete subpopulations of DCs in particular, would express a higher frequency of EGFP than observed in spleen DCs. However, the frequency of EGFP+ cells within lymph node DC subpopulations was much like that of spleen DCs, with the exception of skin-draining lymph nodes (Fig. 3, A-C). This could not be attributed to loss of reporter expression through failure to use the Rosa26 promoter, because all lymph node cells and all CD11cint and CD11chi cells that would be candidate DCs were EGFP+ in Rosa26-EGFP knock-in mice (Fig. 3 D).
###end p 25
###begin p 26
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 0 126 0 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EGFP reporter expression in LysM-Cre &#215; Rosa26-stop<sup>flox</sup>EGFP mice by DCs within lymph nodes that drain intestine, lung, or skin.</bold>
###xml 254 256 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 533 534 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 627 628 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 860 861 856 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 867 869 863 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1280 1284 1276 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 1345 1346 1341 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1464 1466 1460 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1506 1507 1502 1503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1800 1801 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1829 1831 1823 1825 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1877 1879 1871 1873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1885 1886 1879 1880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1922 1923 1916 1917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1935 1936 1929 1930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 892 897 <span type="species:ncbi:10090">mouse</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1957 1961 <span type="species:ncbi:10090">mice</span>
###xml 2023 2028 <span type="species:ncbi:10090">mouse</span>
###xml 2043 2047 <span type="species:ncbi:10090">mice</span>
###xml 2135 2139 <span type="species:ncbi:10090">mice</span>
EGFP reporter expression in LysM-Cre x Rosa26-stopfloxEGFP mice by DCs within lymph nodes that drain intestine, lung, or skin. Stainings for CD11c, CD11b, B220, and CD8alpha were used to delineate various DC subsets within lymph nodes. Conventional CD11chi cells comprised populations in gates 1 and 2 for all lymph nodes (A-C), and also gate 3 for lung-draining lymph nodes (B). Plasmacytoid DCs were in gate 3 (A and C) or gate 4 (B). In skin-draining lymph nodes, gate 4 was considered a DC population because many of the langerin+ cells were found within it (C). The lower flow cytometry plot in C is an overlay of langerin+ cells (black) over all live cells (gray). Monocytes and macrophages were within populations 4 and 5 (A) or 5 and 6 (B and C). The percentage of EGFP within these gated lymph node populations was normalized to the percentage of EGFP+ Ly-6Chi monocytes in the same mouse. In pooled skin-draining lymph nodes, the mean percentage of each DC population relative to the DC gates overall is shown beneath the bar graph. (D) Flow cytometry of a representative lymph node (a skin-draining lymph node) from Rosa26-GFP knock-in mice. Live cells were gated on and plotted to show CD11c versus EGFP. (E) Various lymph nodes and spleens from LysM-Cre x Rosa26-stopfloxEGFP mice were stained with anti-MHC II mAb to identify CD11c+ cells with very high MHC II expression. Plots of these stains are shown on the left, with gated populations of MHC IIhi cells (oval gates) within overall CD11c+ cells (rectangular gates). The mean frequencies of this population in skin- and lung-draining lymph nodes are shown on the top right and are also indicated adjacent to the gate within the dot plots. Data represent the mean +/- SEM. The bottom right plot shows the normalized frequency of EGFP+ cells in these gated MHC IIhi DCs. (F) Analysis of EGFP frequency in MHC IIhi CD11c+ lymph node cells that were langerin+ or langerin-. In each graph, all mice studied are compiled, and each data point corresponds to one mouse. Two to three mice per group were handled per experiment. In E, two experiments were performed with three mice in each. Horizontal bars represent means.
###end p 26
###begin p 27
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 181 189 181 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 215 230 215 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B and C</xref>
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 419 427 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 444 459 444 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, B and C</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1085 1086 1085 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1119 1120 1119 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
None of the classical DC populations in the mesenteric or lung-draining lymph nodes mirrored the percentage of EGFP+ DC populations of the upstream organs (Fig. 3 A, gates 1-3; and Fig. 3 B, gates 1-4; compare with Fig. 2, B and C). As in the spleen, the frequency of EGFP+ cells was elevated in CD11bhiCD11cint and CD11bhiCD11c- lymph node populations, but these are not typically considered classical DC populations (Fig. 3 A, gates 4 and 5; Fig. 3, B and C, gates 5 and 6). Instead, these gates have been suggested to mainly include macrophages and newly recruited monocytes (37). The lack of EGFP expression in most lymph node DCs was not likely caused by dilution of EGFP during the proliferation of EGFP+ DCs that migrated in from the upstream organs, because if the proliferation of DCs accounted for loss of EGFP, we would expect to find DCs with a range of reduced EGFP intensities in the draining lymph node representing DCs that had divided different numbers of times since leaving the upstream organ; instead, EGFP intensity was not different between nonlymphoid organ EGFP+ DCs and draining lymph node EGFP+ DCs, even in the lung, where it has been shown that DC turnover is especially rapid (Fig. S1, available at ).
###end p 27
###begin p 28
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 174 175 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 186 187 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 459 463 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 514 515 514 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 671 679 667 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 696 697 692 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 722 724 718 720 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 730 732 726 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 741 742 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 751 752 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 758 766 750 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 986 994 978 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1208 1209 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1272 1280 1240 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
Like the other lymph nodes, most skin-draining lymph node DCs were EGFP-, but certain populations of DCs within skin-draining lymph nodes, especially those that were langerin+, were EGFP+. Expression of langerin, found on all epidermal DCs and a small fraction of dermal DCs (21, 38), is considered a long-lasting marker of DCs that survey the skin and enter skin-draining lymph nodes through lymphatics (42). Langerin+ cells in resting LysM-Cre x Rosa26-stopfloxEGFP mice represented, on average, 10% of all CD11c+ cells in skin-draining lymph nodes and fell in gates 1 and 4 according to the intensity of CD11c, CD11b, and CD8alpha staining used to divide the subsets (Fig. 3 C). These langerin+ lymph node DCs and CD11bhi CD11chi CD8alpha- langerin- DCs (Fig. 3 C, gate 2) expressed a percentage of EGFP that was elevated above the fraction seen in background populations such as lymphocytes, but the EGFP levels were somewhat lower than any of the upstream populations of skin DCs (Fig. 2 A). Collectively, skin-draining lymph nodes contrasted with other lymph nodes examined, as they showed evidence of containing tissue-derived DCs, with up to 20% of the total lymph node DCs (approximately10% langerin+ cells plus half of the DCs in gate 2 equals approximately20%; Fig. 3 C) possibly arriving from skin lymphatics.
###end p 28
###begin p 29
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 278 280 278 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 528 530 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 609 610 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 636 638 636 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 676 677 676 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 684 686 684 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 709 710 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 807 809 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 815 816 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 837 838 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 840 848 840 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 927 935 927 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 E</xref>
###xml 941 949 941 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 998 1000 998 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1091 1093 1091 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1143 1144 1143 1144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1199 1201 1197 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1224 1225 1222 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1227 1235 1225 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 1302 1303 1300 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1315 1316 1313 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1323 1325 1321 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1333 1341 1331 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 1378 1380 1376 1378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1430 1431 1428 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1453 1454 1451 1452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1461 1463 1459 1461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1506 1507 1504 1505 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1562 1570 1560 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 447 452 <span type="species:ncbi:10090">mouse</span>
DCs highly enriched in MHC II were observed in skin- and lung-draining lymph nodes, present on average in 17 and 9% of total CD11c+ cells, respectively. MHC IIhi DCs were not readily identified in mesenteric lymph nodes or the spleen (Fig. 3 E), although in other studies MHC IIhi cells were found in the spleen (43), indicating that even under specific pathogen-free conditions the phenotype of DCs in the steady state can vary between different mouse colonies. Because migrating DCs have sometimes been defined by being MHC IIhi to a level elevated over other DCs (18, 19), we assessed the frequency of EGFP+ cells within gated MHC IIhi lymph node DCs. The frequency of EGFP+ MHC IIhi DCs was, like langerin+ DCs, elevated in this gate relative to lymph node DCs overall. However, the percentage of MHC IIhi CD11c+ cells that were EGFP+ (Fig. 3 E) fell short of that observed in monocytes and in upstream tissue DCs (compare Fig. 3 E with Fig. 2 A), suggesting that many but not all of the MHC IIhi DCs might arise from defined, upstream tissue DC populations. As expected (18), the MHC IIhi DC gate was partially redundant with the langerin+ gated DCs, because in our analysis 31 +/- 2% of MHC IIhi DCs were also langerin+ (Fig. 3 F). There was no difference in the EGFP frequency in either langerin+ or langerin- MHC IIhi cells (Fig. 3 F), suggesting that some of the MHC IIhi DCs may be migratory dermal DCs that are langerin- and that overall EGFP+ MHC IIhi DCs were equivalent to the sum of langerin+ cells in gates 1 and 4 and DCs in gate 2, as shown in Fig. 3 C.
###end p 29
###begin p 30
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
Given that EGFP+ DCs could not give rise to EGFP- DCs, the failure to observe substantial EGFP expression in the vast majority of lymph node DC populations suggests that upstream organ DCs do not substantially populate lymph nodes in the steady state and certainly cannot account for as many as half of lymph node DCs (17). Clearly, some subpopulations of DCs accumulated in steady-state lymph nodes, most notably langerin+ and MHC IIhi DCs within skin-draining lymph nodes, but these subpopulations maintained a relatively low overall frequency.
###end p 30
###begin title 31
Contrasting with the steady state, DCs from upstream organs are populous in lymph nodes that drain sites of inflammation and immune sensitization
###end title 31
###begin p 32
###xml 40 46 40 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 761 762 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 832 833 832 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 861 863 861 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 888 896 888 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 931 932 931 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 977 985 977 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1060 1068 1060 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1078 1086 1078 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
###xml 1092 1100 1092 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1116 1117 1116 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1133 1134 1133 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1190 1198 1190 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1204 1212 1204 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1224 1225 1224 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1250 1251 1250 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1253 1261 1253 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1278 1280 1278 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1286 1287 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1403 1411 1403 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1422 1425 1422 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1431 1432 1431 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1487 1495 1487 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1497 1505 1497 1505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1686 1687 1686 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1717 1721 1717 1721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 1726 1730 <span type="species:ncbi:10090">mice</span>
One caveat to the conclusion drawn from Fig. 3 is the possibility that EGFP- organ DCs preferentially migrate to draining lymph nodes over their EGFP+ counterparts. To consider this possibility and to be certain that migratory DCs could be detected as EGFP+ cells in lymph nodes if they were present, we experimentally induced large-scale DC migration by applying a fluorescent contact sensitizer to the skin, thereby using one of the most established DC migration assays (3, 44). Tetramethylrhodoamine-5-(and-6)-isothiocyanate (TRITC) was mixed with dibutylphthalate and acetone and applied epicutaneously to trace DC migration (15, 45). As previously reported (45), the migrating population observed in lymph nodes 1 d after sensitization were mainly langerin- cells (not depicted), which are thought to arise from dermal langerin- DCs (45), such as the CD11bhi populations observed in Fig. 2 A. In the draining lymph node, TRITC+ DCs represented >30% of all lymph node DCs (Fig. 4 A) and fell within gates 2 and 4, as shown for skin-draining lymph nodes in Fig. 3 C (compare Fig. 3 C with Fig. 4 A, middle). TRITC+ cells were EGFP+ at the same frequency observed for dermal DCs (compare Fig. 4 A with Fig. 2 A), but TRITC- DCs remained mainly EGFP- (Fig. 4 A). Overall, CD11chi TRITC+ cells in the lymph node phenotypically resembled and showed a similar EGFP frequency as the Dermal 1 population in Fig. 2 A, and CD11cint TRITC+ cells most closely matched the Dermal 3 population in Fig. 2 A (Fig. 4 A). These data indicate that migrating DCs retain expression of EGFP during mobilization to downstream lymph nodes and illustrate that the migrating DC population does not favor EGFP- DCs in LysM-Cre x Rosa26-stopfloxEGFP mice.
###end p 32
###begin p 33
###xml 50 54 50 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 0 162 0 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EGFP reporter expression in LysM-Cre &#215; Rosa26-stop<sup>flox</sup>EGFP mice by DCs that migrate into lymph nodes from upstream organs in response to inflammatory stimulation.</bold>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 554 555 554 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 585 586 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 642 643 642 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 649 651 649 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 730 731 730 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 761 762 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 768 769 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 797 799 797 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 804 807 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 885 886 885 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 892 893 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 980 981 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 987 988 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 998 1001 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1163 1165 1163 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1171 1173 1171 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1196 1198 1196 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1204 1206 1204 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1298 1299 1294 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1308 1309 1300 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1316 1317 1308 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1345 1346 1333 1334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1431 1432 1419 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1441 1442 1425 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1449 1450 1433 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1465 1466 1445 1446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1512 1514 1492 1494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1520 1522 1500 1502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1868 1870 1848 1850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1936 1938 1916 1918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1943 1945 1923 1925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1950 1951 1930 1931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1962 1963 1942 1943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2009 2011 1989 1991 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 2016 2018 1996 1998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 2023 2024 2003 2004 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2035 2036 2015 2016 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2044 2046 2024 2026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 2051 2053 2031 2033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 2058 2059 2038 2039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 2070 2071 2050 2051 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 674 679 <span type="species:ncbi:10090">mouse</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
###xml 1897 1902 <span type="species:ncbi:10090">mouse</span>
###xml 2272 2276 <span type="species:ncbi:10090">mice</span>
###xml 2303 2307 <span type="species:ncbi:10090">mice</span>
###xml 2369 2374 <span type="species:ncbi:10090">mouse</span>
###xml 2389 2393 <span type="species:ncbi:10090">mice</span>
EGFP reporter expression in LysM-Cre x Rosa26-stopfloxEGFP mice by DCs that migrate into lymph nodes from upstream organs in response to inflammatory stimulation. (A) TRITC was applied to skin epicutaneously in a contact-sensitizing solution, and TRITC+ cells in the draining lymph nodes 18 h later were identified (left dot plot, gated area) and further analyzed. The flow cytometry plot on the right shows an overlay of TRITC+ cells (black) over all live lymph node cells (gray) with respect to the expression of CD11c and CD11b. The percentage of EGFP+ cells within TRITC+ and TRITC- lymph node DCs was normalized to the percentage of EGFP+ Ly-6Chi monocytes in the same mouse. Graph shows individual mice per data point. TRITC- DCs refers to a gate on TRITC- CD11c+ DCs that excludes the CD11bhiCD11cint gate that is considered to contain mainly monocytes (reference 37). The TRITC- CD11c+ grouping includes all DCs and the putative monocyte gate, thereby containing all TRITC- CD11c+ and CD11cint cells in the lymph node. (B) PBS or LPS was delivered intranasally (I.N.). 24 h later, live cells from the lung-draining lymph nodes were gated to identify CD11chi CD11blo cells, and gated CD11chi CD11blo cells were examined for CD103 or CD8alpha expression, revealing three subpopulations: CD103+ CD8alpha- (CD103+) lung-derived DCs, CD8alpha+ DCs, and double-negative DCs. Shown is the number (C) or percentage (D) of the CD103+ CD8alpha- (CD103+) DCs, CD8alpha+ DCs, and double-negative DCs within the CD11chi CD11blo gated population (from the FACS dot plot, top left) from the lung-draining lymph nodes treated with LPS (black squares) or with PBS (gray circles) to maintain near steady-state conditions. (E) Graph shows the effect of LPS treatment, used to induce DC migration from the lung, on the expression of EGFP by various populations, normalized to Ly6Chi monocytes within the same mouse. BAL and lung were gated on CD11chiCD11bloCD103+ DCs (CD103+). Lung-draining lymph node was gated on CD11chiCD11bloCD103+ DCs (CD103+), CD11chiCD11bloCD103- DCs (CD103-), and plasmacytoid DCs. Horizontal bars represent means. (F) Percentage of blood monocyte subsets and lymph node DC populations that expressed EGFP with or without intranasal LPS administration (from mice in E). In each graph, all mice studied are compiled, and each data point corresponds to one mouse. Two to three mice per group were handled per experiment. Data represent the mean +/- SEM.
###end p 33
###begin p 34
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 347 348 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 454 455 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 463 464 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 498 500 490 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 506 508 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 514 522 506 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 536 537 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 648 649 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 654 656 646 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 662 670 654 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 843 851 835 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 939 940 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 942 944 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 946 948 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 995 996 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1004 1005 992 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1057 1065 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1126 1134 1114 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 1150 1158 1138 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1190 1191 1178 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1242 1244 1230 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1249 1251 1237 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1257 1265 1245 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 1397 1412 1385 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B and C</xref>
###xml 1458 1459 1446 1447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1498 1513 1486 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, C and D</xref>
###xml 1539 1540 1527 1528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1554 1555 1542 1543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1629 1637 1617 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 1719 1727 1707 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 1781 1782 1769 1770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2012 2014 1996 1998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 2016 2018 2000 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
We next examined the effect of tissue inflammation on populations of DCs in lung-draining lymph nodes. As mentioned earlier, CD103 expression marks approximately half of the pulmonary DCs, and its expression persists after the DC migrates to the downstream, lung-draining lymph node (40, 46). We therefore monitored expression of CD103 by CD8alpha- DCs in the lung-draining lymph node to determine the frequency of this migrated population therein. CD103+CD8alpha- DCs fell within the gate of CD11chi CD11blo DCs (Fig. 4 B). These CD103+ DCs in the lymph node reflected a frequency of EGFP expression expected from analysis of upstream tissue CD103+CD11blo DCs (Fig. 2 B) but comprised a very small component within the gate (<10% gated, and 4% of lymph node DCs overall) when noninflamed lymph nodes from mice treated with PBS were examined (Fig. 4 B). However, when we treated mice intranasally with LPS to greatly enhance DC migration (5, 40, 47) and examined the lymph node 24 h later, CD103+CD8alpha- DCs were the dominant population in the same gate (Fig. 4 B, top left dot plots), and quantification of their absolute (Fig. 4 C) and relative (Fig. 4 D) frequency confirmed that CD103+ DCs were now the majority (60%) of the gated CD11chiCD11blo DCs (Fig. 4 D) and represented 25% of the lymph node DCs overall. LPS treatment led to an increase in the absolute number of all DC populations (Fig. 4, B and C), but migratory populations such as the CD103+ DCs were disproportionally increased (Fig. 4, C and D; and not depicted). CD103+ DCs were EGFP+ to a similar normalized frequency as their upstream tissue counterparts (Fig. 4 E). LPS increased the proportion of all lymph node DC subsets that expressed EGFP (Fig. 4 F), but because it also increased the frequency of EGFP+ monocytes and tissue DCs, it scarcely altered the normalized data. Taking these observations together, we conclude that inflammatory stimuli, such as LPS or mediators like TNF-alpha and IL-1 induced during contact sensitization (48, 49), are generally necessary to provoke substantial accumulation of upstream tissue-derived DCs within lymph nodes that enter by way of the afferent lymphatic vessels, and that, in contrast and against our expectations, in the steady state the lymph node contains few nonlymphoid organ-derived DCs.
###end p 34
###begin title 35
DISCUSSION
###end title 35
###begin p 36
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 576 577 572 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 801 803 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 805 807 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 866 868 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 352 358 <span type="species:ncbi:9606">humans</span>
Historically, several observations led to the development of the view that lymph node DCs arose substantially from lymph-borne DCs that originated in upstream tissues. First, DCs in cannulated afferent lymph are relatively abundant and are clearly involved in transporting antigen. In contrast, committed DC precursors are sparse in the circulation of humans (4). Furthermore, when afferent lymphatics are severed, the lymph node becomes nearly void of DCs (50) and antigen presentation is blocked (51). Recently, the idea that specialized DC subsets-plasmacytoid and CD8alpha+ DCs-enter the lymph node from the bloodstream has been introduced, but this understanding has not modified the belief that many lymph node DCs arise from interstitial nonlymphoid organ DCs that mobilize through lymphatics (16, 17) and may even mature in the steady state as they migrate (19). In this study, we present surprising evidence that most steady-state DCs in lymph nodes that drain a variety of organs by and large do not originate from upstream tissue DCs. Instead, we find that it is only during inflammation that tissue-derived DCs comprise a major fraction of lymph node DCs.
###end p 36
###begin p 37
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1176 1178 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1389 1391 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1889 1891 1889 1891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 2043 2044 2043 2044 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2080 2081 2080 2081 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 1456 1460 <span type="species:ncbi:10090">mice</span>
###xml 2097 2101 <span type="species:ncbi:10090">mice</span>
The model system used herein used LysM-Cre x Rosa26-stopfloxEGFP mice that "report" expression of LysM in neutrophils, monocytes, and macrophages by irreversibly inducing EGFP expression. A much lower frequency of expression is observed in T and B cells, stemming from promiscuous activation of the LysM promoter in some hematopoietic stem cells (31). Although macrophages continue to express lysozyme as they mature (31), this gene is not considered to be a marker for DCs and may be turned off developmentally upon induction of DC differentiation. The current study's comparison between tissue DC populations and those in the lymph node was possible because many tissue DCs, but not most lymph node or spleen DCs, expressed EGFP downstream of lysozyme promoter usage. The discrepancy in the frequency of the EGFP reporter between splenic and nonlymphoid organ DCs is consistent with the possibility that nonlymphoid organ DCs may derive from monocytes or some other lysozyme-positive precursor, but that most lymph node or spleen DCs do not (25). Both lymph node and spleen DCs more closely expressed the frequency of EGFP observed in bone marrow DC precursors called MDPs (24, 37), which do not inevitably differentiate into monocytes and may shut off EGFP as they differentiate into alternative end-stage cells, including DCs. Although complementing former adoptive transfer studies, (23-25) our approach has the advantage of permitting examination of mice with no previous experimental manipulation, thus truly maintaining the steady state. In addition, we examined whole populations, rather than a small proportion of transferred cells that require extrapolation, to make conclusions about what might have occurred in most members of a given population. Though our data are consistent with the possibility that nonlymphoid organ DCs may arise from monocytes, and indeed we used Ly-6Chi monocytes as a reference population throughout this study, our approach cannot prove an origin from monocytes for any population. However, because EGFP+ cells cannot be precursors for EGFP- cells in these mice, the strength of the model lies in its power to reveal which relationships between populations cannot be true.
###end p 37
###begin p 38
###xml 64 65 64 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 91 95 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 788 794 788 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 939 940 935 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1104 1105 1100 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1110 1111 1106 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1117 1118 1113 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1363 1365 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 1377 1379 1373 1375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1677 1679 1673 1675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 1851 1852 1847 1848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1959 1961 1955 1957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1975 1976 1971 1972 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Based on the fact that nonlymphoid organ DCs are frequently EGFP+ in LysM-Cre x Rosa26-stopfloxEGFP mice and lymph nodes DCs are not, we conclude that nonlymphoid organ DCs cannot account for the origin of most steady-state lymph node DCs, with the exception of discrete populations of skin DCs, such as langerin+ DCs, in skin-draining lymph nodes. Because lung and airway DCs are well characterized and possess durable markers such as CD103 that independently enable tracking in the steady state, this conclusion is particularly clear and striking when lung-draining lymph nodes are examined (5, 40, 47). In the small intestine, little information is available as to which LP population best migrates into lymphatics. We found one population of LP DCs with a very low frequency of EGFP (Fig. 2, LP1), such that if they migrated substantially to lymph nodes in the steady state they would go undetected by our method. However, the CD8alpha+ phenotype of these cells is more consistent with the possibility that they are contaminants from Peyer's patches rather than part of the LP proper. The major CD11c+CD11b+MHC II+ cell we identified in the LP expressed a high frequency of EGFP, but little is known about how efficiently these cells migrate into lymphatics. DCs at the epithelial interface migrate to lymph nodes after capturing luminal intestinal antigens (52). The CD11bhi population that was recovered in both the terminal villi and LP preparations is likely to correspond to this DC, given that it copurified to some extent with the epithelium. These DCs had an overall lower frequency of EGFP expression than blood monocytes, suggesting against previous conclusions (25) that they are not completely derived from monocytes. However, a low level of contamination from Peyer's patch DCs might also, as an artifact, reduce the frequency of EGFP+ cells in this population. In any case, though lower in EGFP frequency than monocytes, these villi/LP CD11bhi DCs were EGFP+ to a greater extent than any DC subset in the mesenteric lymph node, supporting the conclusion that these DCs did not comprise a major fraction of DCs in the mesenteric lymph node but are present only to a minor degree.
###end p 38
###begin p 39
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 338 340 338 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 608 609 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 866 870 866 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 921 923 921 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 928 929 928 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 993 1001 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 1141 1145 1141 1145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">flox</sup>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
A caveat to our approach might be that the EGFP- DCs within a tissue preferentially have the capacity to migrate to lymph nodes. However, this is quite unlikely for several reasons. First, in all cases in which we can identify small populations of tissue-derived DCs, by gating on langerin+ DCs in skin-draining lymph nodes or CD103+CD11blo DCs in lung-draining lymph nodes, we see a close reflection of the EGFP frequency observed in the corresponding upstream tissue DC population. Second, during inflammation, upstream tissue-derived DCs are quite abundant in lymph nodes, and there is no bias toward EGFP- DCs. Thus, in all cases in which we analyze DCs confirmed to migrate from upstream organs to lymph nodes, we observe the expected frequency of EGFP. Finally, momentarily disregarding an approach based on analysis of EGFP frequency in LysM-Cre x Rosa26-stopfloxEGFP mice, an examination of total numbers of CD11bloCD103+ DCs in steady-state versus inflamed lung-draining lymph nodes (Fig. 4 B, bottom graphs) leads to a similar conclusion as that drawn from data that depend on the premises made in studies of LysM-Cre x Rosa26-stopfloxEGFP mice.
###end p 39
###begin p 40
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
Although we conclude that the presence of nonlymphoid organ DCs is more minimal than expected in lymph nodes, this finding does not necessarily dispel the possibility that there is a relatively high frequency of DCs trafficking through lymph constitutively. For example, the lifespan of lymph-migrating DCs, especially in the steady state, may be quite brief within downstream lymph nodes. All of the available evidence indeed suggests that DC turnover in general is very rapid in lymph nodes (15, 27). Skin-resident dermal and epidermal DCs may in particular survive and persist in lymph nodes longer than other DC populations (53, 54). Our finding that these skin DC populations were the most enriched nonlymphoid organ-derived DCs in all lymph node examined corresponds with the idea that lifespan may be the major regulator of the presence of migratory tissue DCs within the lymph node.
###end p 40
###begin p 41
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 542 543 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 549 551 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 917 920 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 925 927 921 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1033 1035 1029 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 1047 1049 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 1051 1053 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 1125 1127 1121 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1208 1209 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1510 1512 1506 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1726 1728 1722 1724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 1783 1786 1779 1782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">int</sup>
###xml 1828 1830 1824 1826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 1822 1826 <span type="species:ncbi:10090">mice</span>
Even as ephemeral constituents within lymph nodes, migratory DCs could still play a major role in immunity in the steady state. However, their failure to accumulate in lymph nodes for substantial durations fits best with a role in which they supply antigen, already processed or not, to other DCs within lymph nodes (55, 56). Transfer of antigen from migratory DCs to other DCs may be at least as substantial, or more so, in the steady state as it has been proposed to be during infection (56). The appearance of parietal antigens in CD8alpha+ DCs (10), a population of so-called lymph node-resident DCs that our data uphold do not derive from upstream tissue DCs, suggests that even large fragments of tissue antigens are not restricted within the lymph node to migratory DCs but are instead readily shared with other DCs. Alternatively, migratory DCs may often possess a phenotype distinct from that expected. CD11cintCD11bhi lymph node cells are not considered by most to be classical DCs, and they share this phenotype with Ly-6Clo monocytes (33, 57), making it tempting to consider all such cells as putative monocytes (37). Cells with this phenotype were abundant in steady-state lymph nodes, were EGFP+ like upstream tissue counterparts, and may reflect an important DC type with the capacity to directly present antigen or transfer it to other DCs. Particle-bearing, phagocytic monocyte-derived DCs that emigrate from skin to lymph nodes also express low levels of CD11c and very high levels of CD11b (20). Yet, little consideration has been given to the possibility that these cells have an important role in steady-state lymph nodes or, ultimately, in antigen presentation, in part because of the evidence that CD11chi cells are required for immune priming, even when CD11cint cells are not deleted in CD11c-DTR mice (58).
###end p 41
###begin p 42
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
Because we cannot link lymph node DCs substantially to upstream tissue DCs, more credence may be given to the possibility that lymph node DCs mainly enter lymph nodes during the steady state through high endothelial venules. This notion still requires direct experimental support. Another interesting possibility to be investigated in future work is that the upstream tissue feeds the lymph node with DCs that enter through lymphatics, but that these cells circulate in lymph in an unexpected form, other than as descendents of tissue-resident DCs. The recent evidence that hematopoietic progenitor cells are found in lymph raises the possibility that they might seed the lymph node, although these progenitors were not retained in lymph nodes themselves and were argued to play a more important role in generating tissue DCs during inflammation rather than lymph node DCs in the steady state (59). As our findings challenge long-held views about the role of steady-state trafficking DCs in comprising lymph node populations of DCs, the present work highlights the need to investigate in more detail how lymph nodes are populated by DCs in the steady state, and the relationship between lymph-migrating and nonmigratory DCs in presenting antigen under homeostatic conditions.
###end p 42
###begin title 43
MATERIALS AND METHODS
###end title 43
###begin title 44
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 44
###begin p 45
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">Mice</span>
LysM-Cre mice (29) were crossed to a reporter strain in which the Rosa26 promoter is upstream of a floxed stop cassette and the EGFP gene (30). This cross was provided to us by T. Graf (Centre for Genomic Regulation, Barcelona, Spain) (31), and we subsequently backcrossed the mice 12 generations on the C57BL/6 background before these experiments. Wild-type C57BL/6 and control mice in which EGFP is knocked into the Rosa26 locus for constitutive expression without the need for deletion of a floxed stop cassette (35) were purchased from the Jackson Laboratory. Mice were housed in a specific pathogen-free environment at Mount Sinai School of Medicine and were used in accordance with protocols approved by the Institutional Animal Care and Utilization Committee.
###end p 45
###begin title 46
Cell suspension of spleen, lymph nodes, and nonlymphoid organ DCs.
###end title 46
###begin p 47
Skin-draining lymph nodes (brachial, axillary, and inguinal), lung-draining lymph node (mediastinal), and mesenteric lymph node were excised, teased with needles and digested in collagenase D (Roche) for 30 min at 37degreesC. After digestion, 100 mul of 100 mM EDTA was added for 5 min. Cells were then lightly pressed through a 70-mum nylon filter, washed, collected, and stained for flow cytometry.
###end p 47
###begin p 48
Spleen and lung cell suspensions were initially processed similarly to lymph nodes. However these tissues required an additional step of erythrocyte lysis after the first filtration. Spleen and lung cells were resuspended for 1 min in 1 ml of 1x lysing buffer (BD), followed by the addition of 10 ml of 0.3 mM EDTA/0.06% BSA/HBSS. Cells were then centrifuged at 1,200 rpm for 5 min, filtered, washed, collected, and stained for flow cytometry.
###end p 48
###begin p 49
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
###xml 565 571 <span type="species:ncbi:9986">rabbit</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
To obtain single-cell suspensions of BAL fluid, immediately after death, the trachea of a mouse was exposed and the mouse was positioned upright by inserting one side of a blunt forceps behind the trachea. An 18-gauge needle attached to a 3-ml syringe was inserted through the largest upper-cartilage ring, and the forceps was gently clamped down on the inserted needle. The airways were flushed four times with 1 ml of 0.5 mM EDTA/HBSS. Collected cells were resuspended in FACS blocking solution (HBSS containing 0.1 mM EDTA, 0.03% BSA [wt/vol], and 0.01% of each rabbit and human serum [vol/vol]) and stained for 30 min with conjugated antibodies.
###end p 49
###begin p 50
To isolate LP DCs, part of the small bowel that included the jejunum and ileum was excised by separation from the mesentery. The remaining pieces of mesentery containing fat tissue were removed, and intestines were opened with scissors along the intestinal length and repeatedly washed from intestinal content. Next, intestinal tissues were incubated in the presence of 1 mM DTT (Sigma-Aldrich) at 37degreesC for 20 min and PBS with 1.3 mM EDTA at 37degreesC for 1 h on a shaker. The supernatants that contained a suspension of intestinal epithelial cells, intraepithelial lymphocytes, and a significant fraction of villi DCs were collected, washed and filtered. The remaining pieces of intestinal tissue were subjected to further processing. To enrich the LP DC fraction, the muscularis layer of the gut was separated from the rest with the use of a dissection microscope (model SZ51; Olympus) and discarded, whereas the remaining tissue that contained the villi and underlying submucosa (further referred to as the LP) was subjected to tissue digestion with 0.2 mg/ml of type IV collagenase (Sigma-Aldrich) at 37degreesC for 1 h. These tissues were homogenized, filtered, and washed. Obtained cells suspensions were stained and analyzed by flow cytometry.
###end p 50
###begin p 51
Epidermal and dermal cell suspensions were acquired by splitting cut ears into two pieces. Both pieces were floated in RPMI 1640 medium containing 1.25 mg/ml of Dispase (BD), with the dermis side down overnight at 4degreesC. The next day, the epidermis and dermis were separated, placed in 1 ml of RPMI 1640 medium containing 1.75mg/ml Liberase III (Roche), cut into small pieces, and incubated at 37degreesC for 25 min. After 25 min of incubation, 100 mul of 100 mM EDTA was added for an additional 5 min of incubation. Cells were pressed through a 70-mum nylon filter, washed, collected, and stained for FACS.
###end p 51
###begin title 52
Flow cytometry analysis.
###end title 52
###begin p 53
The following mAbs from BD (except where another vendor is noted) were used for staining: biotinylated mAbs to CD3, B220, Ter119, and I-Ab; PE-conjugated mAbs to CD103 (eBioscience), CD8, B220, I-Ab, or CD115 (eBioscience); PerCP-Cy5.5-conjugated mAbs to Gr-1 (recognizes Ly-6C and Ly-6G) and CD11b; and allophycocyanin (APC)-conjugated mAbs to CD11c and pan-NK (eBioscience). Biotinylated mAbs were detected with streptavidin-conjugated APC (Invitrogen). Conjugated isotype-matched control mAbs were obtained from eBiosciences or BD.
###end p 53
###begin p 54
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 508 509 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
To distinguish MDPs from monocytes in bone marrow (37), we stained for two combinations of lineage markers. Lineage stain 1 used a combination of mAbs to CD3, B220, Ter119, I-Ab, CD11c, and pan-NK (detected in the APC channel). Cells that were negative for these markers were evaluated with lineage stain 2, composed of PerCP-conjugated anti-Gr-1 and CD11b mAbs. CD115+ bone marrow cells positive for lineage stain 2 were monocytes, and those negative for both lineage stains were considered MDPs (CD115+ Lin-) (37).
###end p 54
###begin p 55
###xml 246 250 <span type="species:ncbi:9925">goat</span>
###xml 272 276 <span type="species:ncbi:9925">goat</span>
###xml 282 287 <span type="species:ncbi:10090">mouse</span>
###xml 288 291 <span type="species:ncbi:10116">rat</span>
###xml 292 297 <span type="species:ncbi:9606">human</span>
###xml 549 553 <span type="species:ncbi:9925">goat</span>
Intracellular staining for langerin was performed after extracellular staining was done. Cells were fixed and permeabilized with Cytofix/Cytoperm solution (BD) for 20 min at 4degreesC. Then, cells were washed in 1x Perm/Wash buffer (BD). Control goat IgG (R&D Systems) or goat anti-mouse/rat/human langerin antibody (Santa Cruz Biotechnology, Inc.) was diluted in 1x Perm/Wash buffer at a 1:400 dilution and incubated with permeabilized cells for 20 min at 4degreesC. Cells were washed twice in 1x Perm/Wash buffer, and the secondary antibody, anti-goat PE (Invitrogen), was diluted in 1x Perm/Wash buffer at a 1:300 concentration and incubated with permeabilized cells for 20 min at 4degreesC. Finally, cells were washed once in 1x Perm/Wash buffer, followed by a wash in PBS. Cells were resuspended in PBS and analyzed by flow cytometry.
###end p 55
###begin title 56
Fluorescent labeling of DC migration in the skin.
###end title 56
###begin p 57
###xml 366 368 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
To analyze migrating skin DCs, TRITC (Sigma-Aldrich) was prepared as a stock solution at 100 mg/ml in DMSO and further diluted to a final concentration of 10 mg/ml in a 1:1 acetone/dibutylphthalate mixture (Sigma-Aldrich). The back skin of mice was shaved in three areas, and 25-mul aliquots of the TRITC solution were applied to each area, as described previously (60). 18 h later, brachial, axillary, and inguinal lymph nodes were excised and pooled, stained for flow cytometry, and analyzed.
###end p 57
###begin title 58
Enhanced pulmonary DC migration to the lung-draining lymph nodes.
###end title 58
###begin p 59
###xml 165 167 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
Intranasal delivery of 5 mug LPS (Sigma-Aldrich) in 30 mul PBS was used to enhance pulmonary DC migration to the lung-draining lymph nodes, as previously described (40). PBS alone, administered similarly by intranasal delivery, was used as a control. 24 h after intranasal delivery, mice were killed and tissues were processed for analysis.
###end p 59
###begin title 60
Online supplemental material.
###end title 60
###begin p 61
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Fig. S1 analyzes EGFP intensity to determine if EGFP+ DCs might proliferate and dilute EGFP in the process. Online supplemental material is available at .
###end p 61
###begin title 62
Supplementary Material
###end title 62
###begin title 63
[Supplemental Material Index]
###end title 63
###begin p 64
###xml 60 65 <span type="species:ncbi:69235">Molly</span>
We thank Dr. Florent Ginhoux for helpful discussion and Dr. Molly Ingersoll for critical reading of the manuscript.
###end p 64
###begin p 65
This work was supported by National Institutes of Health grants AI49653 (to G.J. Randolph) and HL086899 (to M. Merad). C. Jakubzick was supported in part by a National Institutes of Health Postdoctoral Training Grant and was the recipient of a Primary Caregiver Technical Supplement from the National Institute of Allergy and Infectious Diseases. G.J. Randolph is an Established Investigator of the American Heart Association.
###end p 65
###begin p 66
The authors have no conflicting financial interests.
###end p 66

